Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 14/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.33 |
| ▸ | JAK3 | P52333 | 1/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3840818 | 0.84 | PARP1 (0.40) | PARP1NR1H2BRD4CREBBPNR1H3 | |
| SCHEMBL3839418 | 0.80 | NR1H2 (0.35) | PARP1NR1H2BRD4CREBBPGPR119 | |
| SCHEMBL3835054 | 0.80 | NR1H2 (0.37) | PARP1NR1H2GPR119NR1H3 | |
| SCHEMBL3839139 | 0.80 | NR1H2 (0.38) | PARP1NR1H2BRD4CREBBPNR1H3 | |
| SCHEMBL3840183 | 0.80 | PARP1 (0.37) | PARP1NR1H2BRD4CREBBPJAK3 | |
| SCHEMBL3840586 | 0.80 | NR1H2 (0.36) | PARP1NR1H2BRD4CREBBPGPR119 | |
| SCHEMBL3835848 | 0.79 | GPR119 (0.37) | NR1H2BRD4CREBBPGPR119NR1H3 | |
| SCHEMBL3837190 | 0.79 | NR1H2 (0.35) | NR1H2BRD4CREBBPGPR119NR1H3 | |
| SCHEMBL3835247 | 0.79 | PARP1 (0.37) | PARP1NR1H2BRD4CREBBPGPR119 | |
| SCHEMBL3858581 | 0.79 | NR1H2 (0.40) | PARP1NR1H2BRD4CREBBPNR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2108642-A1 | JAK INHIBITOR | Kyowa Hakko Kirin Co., Ltd. (JP) | 2009-10-14 | — | — | EP | disclosed |